Global footprint With 40 years in in-vitro diagnostics and 10,000 instruments installed worldwide, ILSA presents a proven track record and potential for upsell of accessories, consumables, and service contracts to existing customers across multiple regions.

Two-site expertise Clear strengths in instrument manufacturing and automated clean-room plastic consumables position ILSA for cross-sell opportunities between instrument upgrades and compatible consumables, as well as potential world-wide supply collaborations.

Market leader niche Leading blood samples storage solutions for Blood Transfusion Centers and Bio-Banks suggest a recurring revenue model through consumables, spare parts, and maintenance tailored to storage systems.

Digital pathology potential Innovations in Anatomo-Cytology and digital analysis chains indicate opportunities to offer integrated digital workflow solutions, chassis upgrades, and IT/software services to labs pursuing end-to-end digitalization.

Growth-ready alignment Despite current revenue under one million, the company’s international market presence and R&D capabilities imply potential partnerships or channel collaborations with mid-size distributors and system integrators to accelerate sales and expand into new geographies.